Heart and Estrogen/Progestin Replacement Study - HERS

Description:

The Heart and Estrogen/progestin Replacement Study (HERS) was a randomized, blinded, placebo-controlled secondary prevention trial of estrogen plus progestin for secondary prevention of coronary heart disease (CHD) in postmenopausal women.